Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORBIT study in active rheumatoid arthritis requiring biologic therapy
2009-011268-13Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of rituximab, etanercept and adalimumab in rheumatoid arthritis (RA) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Mean change in Disease Activity Score (DAS28) between baseline and 12 months. Started Mar 2010; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-011268-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011268-13.